News | October 06, 2014

Grant Awarded to See if Echo Can Detect Significant Coronary Lesions in Chest Pain Patients

ASEF Grant Echo Can Dt Coronary Lesions Chest Pain Patients

Dr. Victor Mor-Avi of the University of Chicago accepts the 2014 ASEF Research Award at Summit 2014.

October 6, 2014 — The ASE Education and Research Foundation hosted a one-day event, Value-Based Healthcare: Summit 2014, Sept. 12 in Washington, D.C., which gathered thought leaders from across the healthcare spectrum to discuss cardiac imaging in the new value-based healthcare paradigm. The Summit culminated with the announcement that the ASE Foundation’s largest research grant in its history, a $200,000 multi-year grant, has been awarded to a research team from the University of Chicago led by Victor Mor-Avi, Ph.D., FASE, director of cardiac imaging research. The team also includes Amit R. Patel, M.D., director of cardiac magnetic resonance imaging and computed tomography; Francesco Maffessanti, Ph.D., post-doctoral scholar; and Roberto M. Lang, M.D., FASE, director of cardiac imaging laboratories.

The proposal, titled Echocardiographic Evaluation of Hemodynamic Significance of Coronary Stenosis in Patients with Chest Pain Undergoing CT Angiography, aims to utilize 3-D echocardiography in patients with acute chest pain as a way to assess the functional significance of coronary stenosis detected by computed tomography coronary angiography (CTCA). According to Mor-Avi, “in the United States alone every year, more than 8 million people require emergency evaluation for acute chest pain, with the estimated cost of over $10 billion.” While non-invasive CTCA has become widely accepted as an effective first-line diagnostic tool in these patients, abnormal findings on this test often result in downstream stress testing. Specifically, choosing appropriate management for patients with intermediate-grade stenosis is challenging because the impact of the disease is unclear.

Mor-Avi explained that this project “will explore the possibility of ‘fusion’ of CTCA and 3-D echocardiography for combined assessment of coronary stenosis and its functional significance, which may help in identifying patients who need intervention, and may thus have important implications in terms of reducing the number of unnecessary tests and resulting in significant savings.”

Cardiovascular ultrasound, also known as echocardiography, is the most widely used imaging technique to diagnose heart disease, performed on more than 20 million patients in the United States each year. Yet in this era of growing Medicare expenditures and federal budget deficits, increasing emphasis has been placed on demonstrating the value of any given test or procedure. As Summit Chair Benjamin F. Byrd III, M.D, FASE noted in his opening address, one of the primary goals of Summit 2014. was to “bring decision makers together to foster proactive conversation on the ways to demonstrate the ‘value’ of imaging, especially echocardiography, in future U.S.-based healthcare.” Providing funding for this research project tangibly demonstrates the Society’s commitment to fostering innovation in clinical care based on data-driven decisions.

As the largest global organization for cardiovascular ultrasound imaging, the American Society of Echocardiography (ASE) is the leader and advocate, setting practice standards and guidelines. Comprised of over 16,000 physicians, sonographers, nurses and scientists, ASE is a strong voice providing guidance, expertise and education to its members with a commitment to improving the practice of ultrasound and imaging of the heart and cardiovascular system for better patient outcomes. 

For more information: www.asecho.org

Related Content

Technology | Focused Ultrasound Therapy | June 19, 2018
EDAP TMS SA has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Focal One device for...
Epsilon Imaging Demonstrates Strain Imaging Integration for Echo Programs at ASE 2018
News | Cardiovascular Ultrasound | June 19, 2018
Clinical practice, along with guidelines and research, have shown that speckle tracking strain imaging can improve...
FDA Clears Bay Labs' EchoMD AutoEF Software for AI Echo Analysis
Technology | Cardiovascular Ultrasound | June 19, 2018
Cardiovascular imaging artificial intelligence (AI) company Bay Labs announced its EchoMD AutoEF software received 510(...
Report Finds Identifying Patients for Lung Cancer Screening Not So Simple
News | Lung Cancer | June 18, 2018
New findings in the current issue of The American Journal of Managed Care suggest that getting the right patients to...
Weight-Bearing CT International Study Group Hosts  Scientific Session at AOFAS Conference
News | Computed Tomography (CT) | June 15, 2018
June 15, 2018 —The Weight-Bearing CT International Study Group will host a scientific session on the benefits of weig
Florida Hospital First in State to Adopt NeuroLogica's BodyTom Elite CT
News | Computed Tomography (CT) | June 14, 2018
June 14, 2018 — NeuroLogica, a subsidiary of Samsung Electronics Co.
Hitachi Medical Systems Europe Named Imaging Supplier for London Prostate Cancer Program
News | Prostate Cancer | June 14, 2018
Hitachi Medical Systems Europe has been awarded the contract to supply six ultrasound systems as part of the RAPID...
Riverain Technologies Issued U.S. Patent for Vessel Suppression Technology
News | Computed Tomography (CT) | June 14, 2018
Riverain Technologies announced that the United States Patent and Trademark Office (USPTO) has awarded the company a...
360 Photos | 360 View Photos | June 14, 2018
This is a 360 degree image from the Canon Aquilion 64-slice...
American Society of Neuroradiology Honors Peter Chang with Cornelius G. Dyke Memorial Award
News | Neuro Imaging | June 13, 2018
Peter Chang, M.D., current neuroradiology fellow at UCSF and recently recruited co-director of the UCI Center for...
Overlay Init